MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Dopamine transporter scan finding in patients with chorea.

    K. Kawabe, K. Miura, K. Ikeda, Y. Iwasaki (Tokyo, Japan)

    Objective: To evaluate dopamine transporter scan findings in patients with chorea. Background: Chorea is nonrepetitive irregular involuntary movement with distal predominance. They are caused by…
  • 2017 International Congress

    Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

    S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the causes of acute illness and its consequences for subsequent inpatient care in patients with Huntington’s Disease (HD). Background: HD is…
  • 2017 International Congress

    Fundamental limit of the alpha-synuclein immunohistochemistry using the endoscopic biopsy from the gastrointestinal tract as a biomarker for Parkinson disease: a case-control study

    C.W. Shin, S.-H. Park, J.Y. Yun, J.H. Shin, H.-K. Yang, H.-J. Lee, S.-H. Kong, Y.J. Jung, G. Shen, H. Kim (Seoul, Republic of Korea)

    Objective: To investigate significance of the Lewy pathology in biopsy and surgical specimen in the gastrointestinal (GI) tract as an in-vivo biomarker for Parkinson disease (PD). Background: Alpha-synuclein…
  • 2017 International Congress

    Neuroinflammation in the substantia nigra is triggered by synucleinopathy and precedes nigral degeneration

    M. Duffy, T. Collier, K. Luk, M. Tansey, K. Paumier, D. Fischer, N. Polinski, C. Kemp, C. Sortwell (Grand Rapids, MI, USA)

    Objective: To determine the relationship between synucleinopathy, neuroinflammation and nigrostriatal degeneration using the rat α-syn PFF model. Background: No therapy exists to halt or slow…
  • 2017 International Congress

    Is the GBA2 a new modifier for Gauchers’s disease and GBA1-related Parkinson’s disease?

    E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to determine the pathological role of GBA2 in the central nervous system(CNS) in Gaucher’s disease (GD) and GBA1-related Parkinson’s disease…
  • 2017 International Congress

    Beneficial and Protective Effects of Withania Someniferais On Mice Brain: A Therapeutic Potential Drug for Parkinson’s Disease

    S. Rajput, S. Sinha (New Delhi, India)

    Objective: Objective of our study was evaluate effect of  Withania Someniferais leaves on Parkinsons brain of mice  Background: Parkinson’s disease (PD), an age-related disorder, is…
  • 2017 International Congress

    Assessment of neurodegeneration and spreading of α-synuclein pathology induced by structurally defined α-synuclein assemblies in wild-type mice

    E. Bezard, M. Bourdenx, L. Arcuri, L. Bousset, R. Melki, B. Dehay (Bordeaux, France)

    Objective: The aim of this study was to investigate, in wild-type mice, the spreading and neurodegeneration induced by intracerebral injection of structurally well-defined α-synuclein assemblies…
  • 2017 International Congress

    Eight contact LFP recordings in the Subthalamic region localize beta source to the dorsal STN

    I. Tamir, C. de Hemptinne, J. Ostrem, P. Starr (San Francisco, CA, USA)

    Objective: The aim of this study was to investigate the electrophysiological characteristics of intra and extra STN LFPs in PD to better locate the source…
  • 2017 International Congress

    Explicit movement control in functional movement disorders is characterized by reduced lateralized beta desynchronisation

    T. Teodoro, A. Meppelink, S. Little, A. Macerollo, R. Grant, M. Edwards (London, United Kingdom)

    Objective: To test whether beta power remains abnormally raised during motor preparation in functional movement disorders (FMD) patients. Background: Excessive attention towards movement control is…
  • 2017 International Congress

    Disappearance of the clinical and imaging manifestations in Wilson’s disease after controlled therapy with tetrathiomolybdate and zinc

    I. Posada, C. Garfia, F. Ostos, A. Ramos (Madrid, Spain)

    Objective: To present a case with Wilson’s disease (WD) whose neurological and imaging alterations disappeared after ammonium tetrathiomolybdate (AT) and zinc acetate (Zn) controlled therapy. …
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley